Clinical Trial Update: A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the efficacy and safety of Prolia (denosumab) for glucocorticoid-induced osteoporosis in Mainland China. The study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

Sponsor: Amgen | Conditions: Glucocorticoid-induced Osteoporosis | Phase 4 | Status: RECRUITING